Gabapentin Increases Glioblastoma Survival

This is a news story, published by ScienceBlog.com, that relates primarily to FDA news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

ScienceBlog.com news

For more news from ScienceBlog.com, you can click here:

more news from ScienceBlog.com

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

glioblastoma treatment

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest brain cancer treatment news, glioblastoma patients news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

glioma treatment

ScienceBlog.com

•

Health

Gabapentin Shows Unexpected Survival Boost in Brain Cancer Patients

Summary

Nutrition label

85% Informative

Gabapentin may offer new hope for patients with glioblastoma, the most aggressive form of brain cancer.

Patients who received gabapentin after surgical tumor removal lived significantly longer than those who didn’t receive the drug.

The most recent FDA -approved therapy for the disease extends survival by roughly 6 months .

By blocking the interaction between cancer cells and healthy neurons, the drug may prevent cancer cells from establishing neural connections.

For patients facing a glioblastoma diagnosis, this research offers new hope by revealing an unexpected weapon in the fight against this aggressive disease.

By repurposing an established medication with a well-understood safety profile, treatment advances could potentially reach patients more quickly than entirely new drugs that require years of development.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful